Adjuvant Transarterial Chemoembolization With Sorafenib for Portal Vein Tumor Thrombus
This randomized clinical trial evaluates the safety and efficacy of transarterial chemoembolization plus sorafenib vs sorafenib alone for patients with hepatocellular carcinoma and portal vein tumor thrombus after surgery.
Source: JAMA Surgery - Category: Sports Medicine Source Type: research
More News: Cancer & Oncology | Carcinoma | Clinical Trials | Hepatocellular Carcinoma | Liver Cancer | Sports Medicine | Thrombosis